Collection of 252 representative proteotypic peptides for tumor associated antigens derived from 61 annotated human proteins for direct usage in mass-spectrometry based proteomics (MRM).
SpikeTides™ Set TAA - light - Specifications
Amount: approx. 50-150 pmol per peptide
Purity: crude
Delivery Format: 96 well microtiter plate
Application(s): Proteomics
Condition(s)/Topic(s): Breast cancer, Burkitt's lymphoma, Cancer, Gastric cancer, Malignant genital cancers, Melanoma, Prostate cancer
Standard Delivery Time: 2-5 days
Are you interested in your custom peptide libraries for your proteomics assays? Choose your sequence, amount and label. We will assist you along the way. Custom SpikeTides Reference Peptides.
JPT's SpikeTides™ Sets TAA
JPT produced a set of proteotypic peptides for the detection of the most relevant tumor associated antigens (TAA) by mass-spectrometry based proteomics. 75 TAAs were selected and prioritized in a NCI pilot project to rank the most relevant cancer antigens to date (Cheever et al., 2009). For 61 of these TAAs JPT'synthesized proteotypic peptides with well documented MRM transition data available (www.srmatlas.org, ISB) resulting in a set of 252 proteotypic peptides for important tumor associated antigens. This set is available with light or isotopically labeled (C-terminal Arg U-13C6;U-15N4 or Lys U-13C6;U-15N2) peptides and is delivered in three 96 well plates.
Benefits of JPT's SpikeTides™ Sets TAA
- Relative quantification of multiple TAA’s from a single sample
- First economic heavy peptide set available
- Multiplexed analysis of disease status and therapeutic success
.jpg "SpikeMix™ ABRF (cross-species standard)")